ATYS-SYSTOE Toe and Finger Systolic Pressure Measuring Instrument
MAIKONG.LTD is a global leader in the research, development, and manufacturing of cutting-edge diagnostic and therapeutic equipment for diabetes. We offer a range of advanced products, including Neuropathy Screening and Detection Equipments, Digital Biothesiometers, Near-Infrared Diabetic Treatment Devices, Diabetic Vascular Neuropathy Treatment Devices, and Vibration Perception Threshold Detectors (VPT-I), among others. One of our most innovative devices is the ATYS-SYSTOE Toe and Finger Systolic Pressure Measuring Instrument, which is an essential tool for early diagnosis and ongoing management of peripheral arterial disease (PAD), particularly in diabetic and renal patients.
Product Overview
The SYSTOE is a fully automated, non-invasive, and painless systolic pressure measurement device. Unlike traditional ankle-brachial index (ABI) tests, which can cause discomfort and require highly trained operators, the SYSTOE provides a more comfortable and convenient alternative. It is designed for use not only by vascular laboratories but also by general practitioners, nephrologists, and diabetes specialists, making it an ideal tool for daily patient monitoring.
This device is particularly beneficial for diagnosing superficial vascular diseases in diabetic patients. It also serves as a cost-effective alternative to more expensive diagnostic procedures, such as comprehensive ultrasound Doppler tests of the lower limbs. After an initial assessment, clinicians can use toe pressures to monitor disease progression and guide further diagnostics.
How the SYSTOE Works
The SYSTOE employs a patented PPG (Photoplethysmography) measurement technique developed by ATYS. This technology uses light-emitting diodes (LEDs) that emit near-infrared light, which is absorbed and scattered by tissue cells. A nearby photodetector senses the changes in reflected light as blood flow varies, which allows the device to measure blood pressure accurately.
During a test, a PPG sensor is placed on the patient’s distal toe or finger. A cuff is applied to the proximal part of the toe or finger. The cuff is automatically inflated until the blood flow is occluded, and then slowly deflated at a controlled rate. The PPG sensor detects the return of blood flow, and the pressure at which this occurs is recorded as the systolic pressure. This method is particularly reliable for diabetic and renal patients, who often suffer from vascular calcification, which can interfere with traditional ABI measurements.
TBI vs. ABI: Why the SYSTOE is Superior
For over 50 years, the ABI test has been the standard method for evaluating and diagnosing PAD. However, ABI testing has several limitations, particularly when used outside of specialized vascular labs. These include the need for extensive operator training to ensure accurate results, patient discomfort from cuff inflation, and the influence of vascular calcification, which can lead to false readings.
The SYSTOE addresses these challenges by offering a more reliable method of measuring distal blood pressure, especially for patients with diabetes or chronic kidney failure. Vascular calcification often renders ABI measurements inaccurate or even unmeasurable. In contrast, the SYSTOE provides accurate and rapid measurements of the toe-brachial index (TBI), which is more reliable for patients with calcified arteries. This makes it an essential tool for improving outpatient evaluations and routine PAD screenings.
Clinical Applications
The SYSTOE is designed for a wide range of clinical uses, including:
- Assessment and Diagnosis of Peripheral Vascular Disease (PVD):
The SYSTOE allows for early detection and ongoing monitoring of peripheral arterial disease in high-risk patients. - Diagnosis of Critical Limb Ischemia (CLI):
For patients at risk of limb loss due to insufficient blood flow, the SYSTOE provides an accurate measurement of the severity of ischemia. - Monitoring Disease Progression in Diabetic and Renal Patients:
The device helps physicians track the progression of vascular complications in diabetic, elderly, and renal failure patients, allowing for timely interventions.
Product Features
- Fully Automated Testing
The SYSTOE automates the entire measurement process, including cuff inflation, deflation, and the display of systolic pressure values. With a simple push of the “START” button, the device completes the test in just three minutes. - User-Friendly Interface
The instrument is designed for ease of use. Simply place the cuff and sensor on the patient’s toe or finger, and the device will automatically perform the measurement. The results are displayed clearly on the screen, ensuring accurate and reliable data collection. - Painless and Non-Invasive
Unlike ankle pressure measurements, which can cause discomfort, the SYSTOE’s testing process is entirely painless, making it more acceptable to patients. - Accurate Low-Pressure Measurement
The SYSTOE is capable of measuring systolic pressures as low as 20mmHg, making it an essential tool for diagnosing and monitoring patients with severe vascular disease. - Reliable for Calcified Arteries
For patients with vascular calcification—a common complication in diabetes and chronic kidney disease—the SYSTOE offers accurate measurements where ABI devices might fail.
Customization Options (OEM/ODM Services)
At MAIKONG.LTD, we offer extensive OEM/ODM services to meet the specific needs of our partners and clients. We provide customization options for product packaging, appearance, and software, including the ability to set a custom boot-up logo. This flexibility ensures that our distributors can market the product under their own brand, enhancing business opportunities and increasing market penetration.
The ATYS-SYSTOE Toe and Finger Systolic Pressure Measuring Instrument is a revolutionary tool in the management and diagnosis of peripheral arterial disease, particularly for patients with diabetes, chronic kidney disease, and vascular calcification. Its non-invasive, fully automated design ensures accurate, reliable, and painless measurements, making it an indispensable device for clinicians worldwide.
By becoming a distributor of MAIKONG.LTD’s innovative products, you are partnering with a global leader in diabetes care and advanced medical technology. Together, we can improve patient outcomes and enhance the standard of care for those living with diabetes.
For more information or to discuss distribution opportunities, please visit our website at www.monkon.us, or contact us via email at lucy@monkon.us. Alternatively, you can reach us by phone or WhatsApp at +008613510907401.
